Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPICE IV: early dexmedetomidine versus placebo in older ventilated critically ill patients
ISRCTN37114000Phase 4Recruiting
- Sponsor
- Cardiff and Vale University Health Board
- Start
- Dec 2023
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in critical illness, sponsored by Cardiff and Vale University Health Board. Primary endpoint: 90-day all-cause mortality. Started Dec 2023; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
critical illness
Beyond the preview
Go deeper on ISRCTN37114000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN37114000.